Abstract
Purpose FES-Cycling can be used to assess neuromuscular performance, however the safety and feasibility of this evaluation method has never been investigated.
Materials and methods an observational prospective study was carried out. The FES-Cycling equipment was set in the evaluation mode. For safety determination, hemodynamic parameters and peripheral oxygen saturation were measured before and immediately after the evaluation protocol, as well as venous oxygen saturation and blood lactate. The creatine phosphokinase level (CPK) was measured before and 24, 48 and 72 hours after the test. The time spent to carry out the entire evaluation protocol and the number of patients with visible muscle contraction were recorded to assess feasibility.
Results Heart rate, systolic and diastolic blood pressure did not change after protocol evaluation, as well as peripheral and venous oxygen saturation (p > 0.05). Moreover, blood lactate did not change (p > 0.05). CPK did not change up to 72 hours after the test (p > 0.05). The time for evaluation was 11.3 (SD = 1.1) minutes. Furthermore, 75% of the patients presented very visible muscle contraction, 25% of the patients presented barely visible and no patients presented non-visible muscle contraction.
Conclusions FES-Cycling based neuromuscular evaluation method is safe and feasible.
Competing Interest Statement
Murillo Frazao is a technical consultant at INBRAMED. Luis Augusto Werlang, Cassio Azevedo, Adelar Kunz and Maikel Peltz are employees of INBRAMED.
Clinical Trial
RBR-10gyv7wn
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We state that this study was approved by University Cardiac Emergency Department of Pernambuco - PROCAPE ethics committee in compliance with the Declaration of Helsinki (opinion number 5.069.827/21, CAAE: 50202821.1.0000.9030) and was registered in the Brazilian Clinical Trial Registration Platform (Number: RBR-10gyv7wn).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
Abbreviations
- ICU
- intensive care unit
- ICU-AW
- intensive care unit-acquired weakness
- FES-Cycling
- functional electrical stimulation associated to cyclergometry
- CPK
- creatine phosphokinase